Position in IQV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,764,784
+$922,611 QoQ
Shares Held
14,309
+32.5% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#385
of 1,082 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026&PARTNERS holds $76,040,383 across 16 Diagnostics & Research names. IQV ranks #7 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
124,363 | $26,358,737 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
28,690 | $14,384,018 | |
| 3 | DHR |
Danaher Corp /De/
|
58,225 | $11,090,698 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
6,313 | $3,323,415 | |
| 5 | WAT |
Waters Corp /De/
|
8,275 | $3,103,456 | |
| 6 | LH |
Labcorp Holdings Inc.
|
10,611 | $2,971,080 | |
| 7 | IQV |
Iqvia Holdings Inc.
This page
|
14,309 | $2,764,784 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
4,426 | $2,343,965 |
All Filings in IQV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,764,784 | 14,309 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,842,173 | 10,802 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,376,723 | 10,544 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,515,721 | 7,980 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,089,577 | 6,914 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $495,931 | 2,813 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $445,684 | 2,268 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $554,509 | 2,340 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $205,731 | 973 | Shares | Sole | 2024-07-24 | |
| No filing history on record for this holder in this stock. | ||||||